Zhou Yang

发表

BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC

S. Xian, Lang Jilu, Tian Zhennan, 2014, BioMed research international.

Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies

Zhongguo Zhou, Jinbin Chen, Li Xu, 2022, Hepatology International.

Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies

Zhongguo Zhou, Jinbin Chen, Li Xu, 2022, Hepatology International.

Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.

Zhongguo Zhou, Jinbin Chen, Yaojun Zhang, 2023, International immunopharmacology.

An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer

Zhongguo Zhou, Jinbin Chen, Li Xu, 2023, BMC Cancer.

Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study

Xiaobing Chen, Meng-Ting He, Zhou Yang, 2023, Thrombosis Journal.

Thermal ablation as an alternative to liver transplantation for hepatocellular carcinoma with clinically significant portal hypertension: propensity score matching study

Lianxiong Yuan, B. Fu, Er-jiao Xu, 2023, Frontiers in Oncology.

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Zhongguo Zhou, Jinbin Chen, Li Xu, 2020, Journal of hepatocellular carcinoma.

Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm

Jinbin Chen, M. Xi, Jun-Cheng Wang, 2024, JHEP reports : innovation in hepatology.